tiprankstipranks
Advertisement
Advertisement

Novanta Earnings Call Highlights Growth Amid Cash Squeeze

Novanta Earnings Call Highlights Growth Amid Cash Squeeze

Novanta ((NOVT)) has held its Q4 earnings call. Read on for the main highlights of the call.

Claim 55% Off TipRanks

Novanta’s latest earnings call struck an optimistic tone, with management emphasizing record sales, robust bookings, and strong new product traction despite notable short-term pressure on margins and cash flow. Executives framed recent headwinds as the cost of protecting customer relationships and completing manufacturing transfers, arguing that these moves set up a cleaner, more profitable 2026.

Record Revenue Caps Novanta’s Biggest Year Ever

Novanta closed Q4 with record revenue, posting 9% reported growth, 2% organic growth, and 4% sequential gains. Full-year 2025 revenue reached $981 million, the highest in the company’s history and providing a larger base from which management plans to grow organically in 2026.

Bookings Surge and Backlog Provides Visibility

Demand indicators were particularly strong as Q4 bookings jumped 25% year over year and 12% sequentially, lifting the company book-to-bill ratio to 1.11. For the full year, bookings rose 14% with a book-to-bill of 1.01, while several businesses reported book-to-bill above one and backlogs roughly 1.5 to 2 times quarterly revenue.

New Product Engine Powers Growth

New product momentum was a standout, with Q4 sales from recently launched offerings climbing more than 80% year over year and driving a vitality index of 24%. For the full year, new product sales rose over 60%, lifting the vitality index to 22%, while company-wide design wins increased more than 20% versus last year.

Profitability Expands on a Non-GAAP Basis

Despite some pressure on gross margin, profitability improved at the operating level as Q4 adjusted EBITDA increased 17% year over year to $61 million, yielding a 23.5% margin. Adjusted diluted EPS grew 20% in the quarter to $0.91, bringing full-year adjusted EPS to $3.29, up 7% from the prior year.

Balance Sheet Swings to Net Cash

The company ended Q4 with $381 million of cash against $260 million of gross debt, resulting in a net cash position of negative $121 million and a net leverage ratio of minus 0.5 times. Management used proceeds from a November capital raise to pay down more than $300 million on its revolving credit facility, enhancing financial flexibility.

Acquisition Capacity Sets Stage for Deals

Novanta now has significant dry powder, having raised more than $600 million and pointing to roughly $1.5 billion of total acquisition capacity. Management signaled that it expects to deploy meaningful capital in 2026, aiming to accelerate growth by adding complementary technologies and expanding in strategic markets.

End Markets Show Broad-Based Strength

The Medical Solutions segment led the way, with Q4 revenue up 16% year over year, including roughly 15% growth in advanced surgery and strong consumables demand. Robotics and Automation revenue rose 6% as the company won business in GPU board drilling and warehouse and humanoid robotics, while Precision Manufacturing bookings improved for the fourth straight quarter.

Gross Margin Hit by Deliberate Delivery Choices

Q4 non-GAAP adjusted gross margin slipped to 45.5%, down 150 basis points from a year ago and 100 basis points sequentially. Management attributed more than 100 basis points of this decline to a deliberate decision to prioritize on-time customer deliveries while executing regional manufacturing transfers, which temporarily inflated costs.

Working Capital and Inventory Weigh on Cash

Regional manufacturing transfers also drove a significant working capital build as Novanta ran dual operations and carried elevated inventory. These actions pushed net working capital roughly 400 basis points higher as a percentage of sales, creating near-term drag on cash flow but expected to unwind once transfers are completed.

Operating Cash Flow Temporarily Weakens

The cash impact was evident in Q4 operating cash flow, which fell to $9 million from $62 million in the prior year period as inventory and other working capital items absorbed cash. For the full year, operating cash flow totaled $64 million, well below last year and prior conversion targets, with management projecting a sharp rebound in 2026.

Equity Raise Creates EPS Headwind

The November equity financing expanded the diluted share count by about 2.7 million, which management estimates will reduce 2026 EPS by roughly $0.22 to $0.24. A one-time all-employee equity grant will add another approximate $0.14 EPS impact in the first half of 2026, creating visible but finite dilution.

Precision Manufacturing Still in Recovery Mode

Within the portfolio, Precision Manufacturing remained the soft spot as Q4 revenue declined 3% year over year, although it grew 8% sequentially. Management described the segment as being in recovery, highlighting accelerating bookings as an early sign that demand trends are improving even if reported revenue lags.

Margins and Cash Miss Prior Expectations

Executives acknowledged that margins and cash flow fell short of the targets laid out on the previous call, largely because they leaned into manufacturing transfers and customer fulfillment. Cost actions implemented in January and the planned completion of transfers by the end of Q2 are expected to remove this short-term drag and support better profitability and cash conversion.

Guidance Signals Growth and Cash Rebound Ahead

For 2026, management guided GAAP revenue to $1.03 to $1.05 billion, implying 4% to 6% organic growth and accelerating trends from Q1 through the back half. They project adjusted gross margin of about 47%, adjusted EBITDA of $245 to $250 million at roughly 24% margin, EPS of $3.50 to $3.65 despite equity-related headwinds, and operating cash flow between $145 and $185 million as manufacturing transfers conclude.

Novanta’s earnings call painted a picture of a company trading short-term margin and cash performance for long-term growth and operational resilience. With record revenue, strong bookings, ample acquisition capacity, and a confident 2026 outlook, management is betting that today’s transitory headwinds will give way to higher profitability and stronger cash generation over the next year.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1